Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Oct 15 | 2019Abbott and Tandem partnership; Livongo partners with VSP Vision CarePurchase Blast
JnJ cover image
$599
Posted in: SGLT2i Oct 15 | 2019J&J Q3 '19 Earnings UpdatePurchase Blast
european medicines agency cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, SGLT2i Oct 14 | 2019Lilly Nasal Glucagon CHMP Opinion This Week (CHMP Agenda October 14-17)Purchase Blast
$599
Posted in: Glucose Monitoring Oct 14 | 2019Abbott Libre 2 US Approval Conspicuously Late?Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucose Monitoring, Insulin Delivery, Other Oct 01 | 2019Sanofi to Unveil New Strategy in December; Novo Obesity Partnership; Lifescan to Expand BGM AccessPurchase Blast
sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Insulin Delivery, SGLT2i Sep 24 | 2019Sanofi DCV R&D Head Set to Move OnPurchase Blast
1 2 3 29

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please Login. If you have any questions or would like to subscribe to our services, please contact Brady.